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Hyperplasia of the parathyroid gland without secondary hyper- in experimental-animal models have shown that a high
parathyroidism. P diet can accelerate uremia-induced parathyroid hyper-
Background. Low dietary phosphorus (P) prevents parathy- plasia and SH while P restriction can prevent the devel-roid gland (PTG) hyperplasia and the development of second-
opment of both abnormalities [6–8]. This effect of P doesary hyperparathyroidism (SH) in uremic rats. The present study
not appear to involve changes in serum calcium or 1,25-explores the effects of P restriction on parathyroid hormone
(PTH) synthesis and secretion and PT cell growth in rats with (OH)2D3. Lopez-Hilker et al demonstrated in dogs with
established SH and PTG hyperplasia. advanced renal failure that serum P levels could modu-
Methods. Normal and 5/6 nephrectomized rats were fed a late serum parathyroid hormone (PTH) independent ofhigh P (0.8%) diet. After two weeks, the normal rats and half
changes in serum ionized calcium (ICa) or 1,25-(OH)2D3of the uremic rats were sacrificed (U-HP) while the remaining
[9]. Similar results were seen in patients with advanceduremic rats were switched to a low P (0.2%) diet (U-HP-LP).
Results. High dietary P induced a significant increase in se- renal failure [10, 11]. The mechanisms by which P con-
rum P, PTH, and PTG weight, but not ionized calcium com- trols PTH synthesis and secretion are not clear. While
pared to normal animals fed the same diet (N-HP). P restriction an increase in PTH mRNA in uremic rats with a highreturned serum P and PTH to normal levels by one week. In
dietary P intake has been reported [12], we have failedcontrast, PTG size did not regress and glands remained enlarged
to detect differences in PTH mRNA in the PTG fromfor up to eight weeks with no evidence of apoptosis. Ribo-
nuclease protection assay and metabolic labeling studies dem- uremic rats fed high or low P diets despite marked changes
onstrated similar PTH/actin mRNA ratios and 35S-labeled PTH in PTH [8].
among the three groups. Intracellular intact PTH was higher in
The present study was designed to gain insight intoU-HP and U-HP-LP rats compared to N-HP animals with no
potential mechanisms behind the effects of dietary Pdifferences between the two uremic groups. PTG-PTH content
correlated only with PTG weight, and serum PTH only with restriction on established hyperparathyroidism and PTG
serum P. The PTG secretory response to calcium remained intact. hyperplasia. Specifically, we assessed the mechanisms
Conclusions. In established chief-cell hyperplasia, P restric- mediating the short-term control of PTH synthesis and
tion restores normal serum PTH levels without affecting PTG
secretion as well as PT cell apoptosis in rats in responsehyperplasia, PTH synthesis, PTG cytosolic PTH or the PTH
to P restriction.secretory response to calcium, suggesting an impaired exo-
cytosis of PTH.
METHODS
Animals and dietsSecondary hyperparathyroidism (SH) and the accom-
panying hyperplasia of the parathyroid glands (PTG) are Renal insufficiency was induced in female Sprague-
among the most consistent pathogenic findings in patients Dawley rats (200 to 225 g) by 5/6 nephrectomy. This
with chronic renal failure. The importance of dietary phos- procedure involves the ligation of most of the branches
phorus (P) intake in the progression of SH in patients on of the left renal artery followed by right nephrectomy.
chronic hemodialysis is well known [1–5]. Several studies The rats were divided into two groups: (1) uremic rats
fed a high P diet (0.8% P and 1.0% Ca) for two weeks
(U-HP), (2) uremic rats fed the same high P diet for twoKey words: uremic hyperphosphatemia, parathyroid hyperplasia, ure-
mia, dietary phosphorus, exocytosis of PTH, calcium response. weeks followed by a low P diet (0.2% P and 0.5% Ca)
for one to eight weeks (U-HP-LP). A group of normalReceived for publication May 24, 2001
rats fed the high P diet for two weeks (N-HP) served asand in revised form September 13, 2001
Accepted for publication November 2, 2001 a control. Studies on the reversal of SH were performed
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were switched to a LP diet. Other studies in the U-HP-LP was made using T7 RNA polymerase and a reverse tran-
scriptase-PCR cDNA cloned into pCRII (Invitrogengroup were done one week after the rats were switched to
the low P diet. At the end of each experimental protocol, Corporation, San Diego, CA, USA). The sizes of the ribo-
probes and protected fragments were 380 and 340 forthe rats were killed, blood was drawn from the dorsal
aorta for ICa, P, creatinine (Cr) and intact PTH determi- PTH and 280 and 250 bases for -actin, respectively. RPA
was performed as previously described [13]. Briefly, totalnations, and parathyroid glands were microsurgically re-
moved and weighed using a microbalance (Cahn C-31; RNA from each PTG pair was mixed with the 32P-labeled
riboprobes for PTH and -actin. After hybridization atOrion Instruments Inc, Boston, MA, USA).
45C for 16 hours, the samples were digested with ribo-
Measurement of cytosolic intact PTH in nuclease T-1 and then with proteinase K. The protected
parathyroid glands RNA fragments were extracted with phenol-chloroform,
precipitated with ethanol, and resolved on a 5% poly-The parathyroid glands were transferred to 500 L of
a Tris buffer (1 mmol/L Tris-HCl, and 100 mmol/L NaCl, acrylamide gel containing 8.3 mol/L urea. The gel was
dried, and the bands were quantitated using a phosphor-pH 7.5) containing 100 mmol/L dithiothreitol (DTT) and
protease inhibitors [0.1 mmol/L phenylmethylsulfonyl imager (Model 445; Molecular Dynamics, Sunnyvale, CA,
USA). PTH mRNA was normalized to -actin mRNA.fluoride (PMSF), 1 g/mL leupeptin, 1 g/mL pepstatin
A and 15 g/mL aprotinin]. The glands were sonicated
Measurement of 35S-labeled PTH in rat parathyroidon ice three times for 30 seconds. An additional 500 L
gland organ cultureof Tris-HCl buffer was added to the sonicate, which was
then stored at 80C until further analysis. Immediately Fresh parathyroid gland pairs were placed in ice-cold
methionine-free DME/HAMS F12 media containingprior to analysis, samples were centrifuged for five min-
utes at 10,000  g and the supernatant was analyzed for 1.25 mmol/L Ca and 1 mmol/L P. Gland pairs (2 pairs
per well) were incubated for 30 minutes at 37C in anPTH using an immunoradiometric assay specific for intact
rat PTH (Immutopics Inc., San Clemente, CA, USA). atmosphere of 95% oxygen. They were then transferred
to fresh media containing 100 Ci of 35S-labeled methio-
PTH secretion in response to a hypocalcemic stimulus nine and incubated for an additional hour. The media
was retained and the glands were placed in 500 L of 2Rats were anesthetized with a solution of 3.6% chloral
hydrate in saline (10 mL/kg). The left femoral artery was lysis buffer (100 mmol/L Trizma base, 1.5 mol/L NaCl,
10 mmol/L CaCl2, 0.2% NaN3, 2.0% Renex-30 and 1cannulated using polyethylene tubing and a pretreat-
ment sample of blood was obtained. Each rat then re- mmol/L AESBF, pH 8.5), and sonicated on ice two times
for 30 seconds each. After an aliquot was taken for DNAceived an IP injection of ethylenediaminetetraacetic acid
(EDTA; 200 mg/kg) in isotonic saline. After 30 minutes determination, the samples were incubated with protein
G-sepharose (PGS) and normal goat serum for one hourthe rats were exsanguinated via the dorsal aorta. The
temporal effect of an intraperitoneal injection of EDTA at 4C and then centrifuged for five minutes at 10,000 g.
The pellet was retained for nonspecific lanes, and theon serum calcium and PTH had been previously deter-
mined. The maximal response for the decrease in serum precleared supernatant was incubated overnight at 4C
with an antibody specific for the N-terminal portion ofcalcium and increase in serum PTH was found to occur
between 15 and 30 minutes. A time point of 30 minutes the PTH molecule. Protein G-sepharose was added and
the samples were incubated an additional hour. Afterwas therefore chosen for the present study. Blood sam-
ples were kept on ice until centrifugation and serum centrifugation, the pellets were washed several times
with a buffer containing (10 mmol/L Trizma base, 150collection. Serum was stored at 20C until analysis of
intact rat PTH. mmol/L NaCl, 1% Triton X-100, 1% deoxycholate) and
boiled in 50 mL of sodium dodecyl sulfate (SDS) loading
Analysis of pre-pro-PTH mRNA dye for five minutes. Samples were resolved by SDS
polyacrylamide gel electrophoresis (SDS-PAGE) and in-Rat parathyroid gland pairs were placed in a microfuge
tube containing 250 L of RNAzol (Cinna Biotex, tact and N-terminal PTH bands were quantified by the
phosphorimager as described above.Friendswood, TX, USA), immediately frozen in liquid
nitrogen and stored at 80C. Prior to ribonuclease pro-
Analysis of apoptosistection assay (RPA), parathyroid gland pairs were ho-
mogenized using a plastic pestle. Total RNA was isolated To identify apoptosis in situ, paraffin sections from
parathyroid glands were deparaffinized in xylene andas directed by the manufacturer. Riboprobes for rat PTH
were produced using SP6 RNA polymerase and a tem- labeled with terminal deoxynucleotidyl transferase (TdT)
as previously described [14] using the method of TdT-plate containing bases 122–461 of the coding sequence
of the rat PTH gene (provided by Jeremiah Morrissey, mediated dUTP-biotin nick end labeling (TUNEL).
TdT was omitted from the staining procedure for controlPh.D., Washington University). A riboprobe for rat actin
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Table 1. Effects of dietary phosphorus on body weight and serum
chemistries in normal and uremic rats
N-HP U-HP U-HP-LP
Number of rats 10 6 5
Body weight g 242.22.6 223.04.1 226.02.2
Creatinine mg/dL 0.610.03 1.370.07b 1.340.07b
Ionized calcium mg/dL 4.690.05 4.790.07 4.760.07
Phosphorus mg/dL 5.760.15 7.870.54a 5.620.12c
The data are expressed as mean  SEM. Abbreviations are: N, normal; U,
uremic; HP, high phosphate diet for 2 weeks; HP-LP, 2 weeks of the high
phosphate diet followed by a low phosphate diet.
aP  0.01 vs. N-HP
bP  0.001 vs. N-HP
cP  0.01 vs. U-HP
sections. The sections were counterstained with hema-
toxylin. Sections of prostate from an orchiectomized rat
were used as a positive control. Red staining identified Fig. 1. (A) Effects of two weeks of high dietary phosphorus (HP) or
two weeks of high dietary phosphorus followed by one week of lowapoptotic nuclei.
dietary phosphorus (LP) on serum parathyroid hormone (PTH) in
uremic (U) rats. Results from normal rats (N) fed the high phosphorusBiochemical determinations
for 2 weeks are shown for comparison. N  10 for the N-HP group,
N  6 for the U-HP group and N  5 for the U-HP-LP group. *P Ionized calcium was measured using an ICa-specific
0.001 vs. N-HP and **P  0.01 vs. U-HP. (B) The correspondingelectrode (Model ICA-1; Radiometer, Copenhagen, Den-
parathyroid gland weights for the rats shown in panel A. *P  0.001
mark). Serum P and Cr were determined by autoanalyzer vs. N-HP. Results are expressed as mean  SEM.
(COBAS MIRA Plus, Branchburg, NJ, USA). Unless
specified, all other reagents were obtained from Sigma
Chemical Co. (St. Louis, MO, USA).
As shown in Figure 1A, serum PTH increased in U-HP
Statistical analyses rats compared to normal animals fed the same diet
(U-HP, 159.4  32.6 pg/mL vs. N-HP, 32.0  4.9 pg/mL;All data are expressed as mean  SEM. The unpaired
P  0.001). One week of P restriction normalized serumt test was used for comparisons between any two of the
PTH (U-HP-LP, 33.0  6.5 pg/mL). The increase inthree experimental groups. Paired t test was used for
serum PTH was accompanied by a marked increase indetermining statistical significance within a particular ex-
parathyroid gland weight (N-HP, 0.70  0.06 vs. U-HP,perimental group. P  0.05 was considered significant.
1.20 0.09 g/kg body wt; P 0.001; Fig. 1B). Although
switching uremic rats from a HP diet to a LP diet normal-
RESULTS ized serum PTH, PTG weight did not decrease (U-HP-
The effects of P restriction on cytosolic PTH, PTH LP, 1.20  0.14 g/kg body wt). P restriction could not
secretory capacity, PTH synthesis, and regression of PTG reduce the size of the PTGs even after eight weeks. In
size were studied in rats with established PT hyperplasia fact, there were no apoptotic cells detected at 1, 2, 4
induced by a diet high in P. SH was established in a or 8 weeks (data not shown). In addition, serum PTH
group of uremic rats by two weeks of high dietary P correlated positively with serum P in these rats (r 
intake. At that time, half of the rats were sacrificed to 0.948, P  0.0001; Fig. 2).
assess the degree of SH and the remaining rats were
Effect of P restriction on intracellular PTH contentswitched to a diet low in P (U-HP-LP). A group of
To determine if the levels of intracellular PTH werenormal rats fed the high P diet for two weeks (N-HP)
lowered by dietary P restriction, the study was repeatedalso was studied.
and the intact PTH in PT cell lysates obtained from the
Effect of P restriction on three groups of rats was measured. The body weights
secondary hyperparathyroidism were similar in all three groups of animals (N, 223.1 
3.3 g; U-HP, 215.6  4.3 g; U-HP-LP, 216.3  4.7 g). AsAfter two weeks of uremia and a high P diet, serum
Cr and P increased significantly compared to normal in the previous group of uremic rats, serum Cr increased to
the same degree (U-HP, 1.36  0.06 mg/dL; U-HP-LP,animals fed the same diet, but ICa remained unchanged
(Table 1). One week of P restriction, while having no 1.30  0.06 mg/dL) but was double that of the normal
group (0.60  0.02 mg/dL). PTG weight also doubled ineffect on serum ICa or Cr, returned serum P to normal
levels in uremic rats. the uremic groups compared to normal animals (N-HP,
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Fig. 2. Correlation analysis of between serum intact PTH and serum
phosphorus levels in the two groups of uremic rats (r  0.948; P 
0.0001). Symbols are: () uremic rats fed the high-phosphorus diet for Fig. 4. Correlation analysis of between PTG weight and PTG-PTH
two weeks (U-HP); () uremic rats fed the high-phosphorus diet for content in all three groups of rats. Symbols are: () normal rats fed
two weeks followed by the low-phosphorus diet for one week (U-HP- the high-phosphorus diet for 2 weeks (N-HP); () uremic rats fed the
LP). N  6 for the U-HP group and N  5 for the U-HP-LP group. high-phosphorus diet for 2 weeks (U-HP); () uremic rats fed the high-
phosphorus diet for 2 weeks followed by the low-phosphorus diet for
1 week (U-HP-LP). N  10 for the N-HP group, N  6 for the U-HP
group and N  5 for the U-HP-LP group; r  0.889; P  0.0001.
rected by DNA content (N-HP, 3.2  0.30 ng/g DNA;
U-HP, 5.2  0.80 ng/g DNA; U-HP-LP, 5.5  0.06
ng/g DNA; Fig. 3B). In addition, regression analysis
revealed a direct correlation between PTG weight and
PTG-PTH content (r  0.889, P  0.0001; Fig. 4).
Effect of P restriction on PT gland secretory capacity
The ability of a low dietary P intake to affect the capac-
ity of hyperplastic PTGs to secrete PTH in response to a
hypocalcemic stimulus was examined. Figure 5A shows
that 30 minutes after an IP injection of 200 mg/kg of
EDTA, ICa decreased similarly in all three groups of
rats (N-HP, from 4.50  0.04 to 2.31  0.09 mg/dL;
U-HP, from 4.55  0.04 to 2.67  0.11 mg/dL; and
Fig. 3. (A) Effects of two weeks of high dietary phosphorus or two U-HP-LP, from 4.65 0.04 to 2.69 0.12 mg/dL). Figure
weeks of high dietary phosphorus followed by one week of low dietary 5B shows that the decreases in ICa were accompanied
phosphorus on cytosolic parathyroid gland PTH in uremic rats. Results
by increases in serum PTH levels in all groups (N-HP,from normal rats fed the high phosphorus for 2 weeks are shown for
comparison. N  10 for the N-HP group, N  6 for the U-HP group 27.2  5.6 to 113.3  4.6 pg/mL; U-HP, 73.0  8.6 to
and N  5 for the U-HP-LP group. *P  0.01 vs. N-HP. (B) This graph 225.9  18.7 pg/mL; and U-HP-LP, 29.3 6.2 to 171.4 
shows the same results corrected by DNA content. *P  0.01 vs. N-HP.
10.0 pg/mL). The increments by which serum intact PTHResults are expressed as mean  SEM.
increased in both uremic groups was comparable (U-HP,
152.9  21.5; U-HP-LP, 142.1  10.1 pg/mL), and was
almost twice that of normal rats (86.1  9.5 pg/mL). The
0.63  0.04 g/g body weight; U-HP, 1.33  0.14 g/g serum chemistries and PTG weights in these rats were
body weight; U-HP-LP, 1.15  0.07 g/g body weight), not different from those in the first study (data not
but the PTG weights of the two uremic groups were not shown).
different. As shown in Figure 3A, the increase in PTG
Effect of P restriction on PTH synthesisweight in the U-HP group was accompanied by an in-
crease in cytosolic PTG-PTH content (N-HP, 5.1  0.70 To ascertain if a reduction in PTH synthesis was re-
ng/gland vs. U-HP, 10.3  1.4 ng/gland; P  0.001). sponsible for the decrease in serum PTH levels seen
Switching rats to the low P diet, while producing a after dietary P restriction, the studies were repeated to
marked decrease in serum PTH, did not decrease cyto- analyze PTH mRNA levels and de novo synthesis of
solic PTG-PTH (U-HP-LP, 13.9 2.5 ng/gland). Similar PTH by 35S metabolic labeling. Ribonuclease protection
assay (RPA) revealed no significant difference in theresults were obtained when cytosolic PTG-PTH was cor-
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Fig. 6. (A) Effects of 2 weeks of high dietary P or 2 weeks of high
Fig. 5. (A) Effects of an IP injection of 200 mg/kg of EDTA on serum dietary P followed by one week of low dietary P on the PTH/-actin
ionized calcium in uremic rats fed a high P diet for 2 weeks or a high mRNA levels in parathyroid glands from uremic rats. Results from
P diet for 2 weeks followed by one week of a low P diet. Results from normal rats fed the high P for 2 weeks are shown for comparison. N 
normal rats fed the high P for 2 weeks are shown for comparison. 5 for the N-HP group, N  5 for the U-HP group and N  4 for the
Symbols are: () values prior to the EDTA injection; ( ) values ob- U-HP-LP group. (B) Effects of 2 weeks of high dietary P or 2 weeks
tained 30 minutes after the EDTA injection. N 7 for the N-HP group, of high dietary P followed by one week of low dietary P on 35S incorpora-
N  5 for the U-HP group and N  6 for the U-HP-LP group. (B) tion in newly synthesized PTH in parathyroid glands from uremic rats.
Effects of an IP injection of 200 mg/kg of EDTA on serum intact PTH Results from normal rats fed the high P for 2 weeks are shown for
in the same rats shown in panel A. *P  0.01 vs. pre-values. Results comparison. N  5 for the U-HP group and N  5 for the U-HP-LP
are expressed as mean  SEM. group. Results are expressed as mean  SEM.
PTH/-actin mRNA ratio among the three groups of no effect of P on PTH mRNA either in vivo in uremic
rats (N-HP, 0.080  0.025; U-HP, 0.108  0.010; U-HP- rats or in vitro in PTG organ culture [8]. Other investiga-
LP, 0.081 0.020 relative intensity/g PTG wt; Fig. 6A). tors have shown in vivo that low dietary P decreases [12]
Again, serum chemistries from these rats were similar and high dietary P increases [12, 15] PTH mRNA in
to those in the first study (data not shown). In vitro rat parathyroid glands. Different from studies in our
metabolic labeling studies using 35S-methionine showed laboratory, Kilav, Silver and Naveh-Many [12] used nor-
no significant difference in the ability of parathyroid mal weanling rats while Hernandez et al [15] studied
glands from either uremic group to synthesize new PTH normal rats at much shorter time points. Both of these
(U-HP, 378.5  72.9; U-HP-LP, 428.2  39.9 relative studies also used diets higher in P (1.2%) compared to
intensity/g PTG wt; Fig. 6B). the 0.8% P diet in our studies. In addition, Moallem et
al reported the existence of proteins in the parathyroid
glands that bind the 3	 untranslated region of PTHDISCUSSION
mRNA preventing transcript degradation [16]. These
This study in uremic rats demonstrates that P restric- proteins are increased by hypocalcemia and decreased
tion can reverse the secondary hyperparathyroidism in- by hypophosphatemia, suggesting that P restriction may
duced by a high P diet but cannot regress the parathyroid reduce serum PTH by decreasing the stability of PTH
gland size. The decrease in serum PTH induced by P mRNA, thus inducing transcript degradation. Under our
restriction is not the result of a reduction in de novo experimental conditions, however, PTH mRNA levels
synthesis of PTH or a fall in cytosolic PTG-PTH levels. do not change. While it is clear P restriction decreases
Since PTH secretory pathways are intact, as demon- PTH, the mechanisms by which it does so are still contro-
strated by the conserved secretory response to a hypocal- versial and require further study.
cemic stimulus, P restriction appears to reduce serum The results from the present study do not rule out the
PTH by impairing PTH secretion. possibility that dietary P restriction may increase the
The role of P in PTH synthesis is still unclear. In intracellular degradation of PTH. Intracellular PTH deg-
hyperplastic parathyroid glands no effect of P restriction radation increases in response to hypercalcemia [17, 18],
on PTH synthesis was seen as demonstrated by PTH but the effect of P on this process is not known. Recent
mRNA levels and metabolic labeling studies. This is work in humans has shown that in addition to intact
PTH (amino acids 1-84), there is a biologically inactivesimilar to earlier reports from our laboratory, showing
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fragment (likely hPTH 7-84) that also is measured by doses of 1,25-(OH)2D3 and hypercalcemia also failed to
induce apoptosis [31].some commercially available ‘intact’ PTH assays [19].
In summary, the effects of a low P diet in decreasingAlthough it is thought that the rat PTH IRMA kit used
serum PTH in parathyroid cell hyperplasia induced byin these studies does not detect this biologically inactive
renal failure is independent of the secretory mechanismfragment, there are no definitive studies to confirm this
regulated by ICa. P restriction does not affect the synthe-(Jeff Levine, personal communication; Immutopics Inc.).
sis of PTH or induce PT cell apoptosis in establishedHowever, our laboratory demonstrated a positive corre-
parathyroid hyperplasia. From the clinical point of view,lation between inactive PTH fragments and plasma cal-
although P restriction may improve secondary hyper-cium but not plasma P in dialysis patients [19]. Since the
parathyroidism, patients with parathyroid hyperplasialevels of fragments do not correlate with serum P, it is
and enlarged parathyroid glands remain at risk for in-unlikely that serum or cytosolic non-(1-84) PTH (likely
creased PTH secretion during hypocalcemic or hyper-7-84) fragment levels differ in the two uremic groups.
phosphatemic episodes.The PT glands from both uremic groups had the same
level of cytosolic PTH and the same magnitude of secre-
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